Latest Market Expansion News

Senetas Corporation has streamlined its operations following the sale of Votiro, reporting a strong financial position and unveiling plans for a significant capital return and share consolidation.

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

Volt Group Limited is set to acquire Perth-based 4D Delta Pty Ltd for $7.25 million, adding a profitable digital asset inspection business to its portfolio. The acquisition is supported by a $4 million capital raise and aims to accelerate Volt’s growth in technology-enabled resource services.

City Chic Collective has reversed its fortunes with a $15 million EBITDA turnaround in FY25, driven by strategic restructuring and strong ANZ growth. The company eyes a debt-free 2025 close and cash flow positivity in FY26 amid cautious optimism for US market expansion.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

Shaver Shop Group Limited reported steady sales of $219 million for FY25, with a notable 2.1% rise in gross profit driven by its private brand Transform-U. The company’s strategic focus on exclusive products and store network optimization sets a positive tone for 2026.

Pacific Current Group has confirmed key leadership appointments with Michael Clarke named Managing Director and CEO, and Ron Patel taking on the role of Acting CFO, signaling continuity and financial stewardship.

Xero Limited reports a robust 20% revenue increase in H1 FY26, driven by strong subscriber growth and the strategic Melio acquisition. The company’s innovative AI platform and improved profitability underscore its confident path toward accelerated US market expansion.

Australian Vintage reports a modest sales dip in FY25 but charts a clear path to cash flow neutrality and growth through innovation and strategic acquisitions.

The FDA's removal of the black box warning on hormone replacement therapies marks a pivotal shift for Mayne Pharma, potentially unlocking new market opportunities and reshaping women’s health treatment.

Linius Technologies has named Anthony Baker as its new CEO and Brent Jones as permanent Chair, marking a strategic leadership shift aimed at driving growth and operational efficiency.

Aristocrat Leisure reported robust FY25 results with 11% revenue growth to A$6.3 billion and a 12% rise in NPATA, fueled by strong performances across its gaming segments and strategic acquisitions. The company signals continued profit growth in FY26, underpinned by organic expansion and market share gains.